4//SEC Filing
Prior Stephen David 4
Accession 0000950170-25-030032
CIK 0001880438other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:19 PM ET
Size
7.5 KB
Accession
0000950170-25-030032
Insider Transaction Report
Form 4
Prior Stephen David
Chief Strategy Officer
Transactions
- Award
Common Stock
2025-02-26+28,000→ 61,313 total - Award
Stock Option (right to buy)
2025-02-26+56,000→ 56,000 totalExercise: $1.13Exp: 2035-02-25→ Common Stock (56,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.
- [F2]Includes (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 and (b) 12,031 RSUs which shall vest on January 1, 2026, in each case, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0002042268
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:19 PM ET
- Size
- 7.5 KB